RF
EVH icon

Rubicon Founders’s Evolent Health EVH Stock Holding History

Rubicon Founders’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3M Hold
5,816,123
– – 9.64% 2
2025
Q4 		$23.3M Hold
5,816,123
– – 14.14% 2
2025
Q3 		$49.2M Buy
+5,816,123
New +$56.4M 24.67% 2

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rubicon Founders's EVH Position: Q1 2026 in Review

Rubicon Founders held its Evolent Health (EVH) position steady in Q1 2026 at 5,816,123 shares worth $13.3M. The position accounts for 9.64% of the portfolio, ranked #2.

Rubicon Founders first reported a position in EVH in Q3 2025 and has held it in 3 quarters since. The position peaked at $49.2M in Q3 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Rubicon Founders held 5,816,123 shares of Evolent Health worth $13.3M as of Q1 2026.
  • Rubicon Founders left its Evolent Health share count unchanged in Q1 2026.
  • Evolent Health made up 9.64% of Rubicon Founders's portfolio in Q1 2026, its #2 holding.
  • Rubicon Founders first reported a position in Evolent Health in Q3 2025 and has held it in 3 quarters since.
  • Rubicon Founders's Evolent Health position peaked at $49.2M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Rubicon Founders's 13F filing for Q1 2026, filed 15 May 2026.